All In Biotech

Drug Trial Radar · NCT04848506

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

900

Planned (sponsor's estimate)

Start

May 6, 2021

Primary completion

Mar 2029

Study completion Mar 2029

Sponsor

Lead sponsor
CytokineticsIndustry
Sponsor type
Industry
First posted
Apr 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect long-term safety and tolerability data for aficamten.

Conditions

  • Symptomatic Hypertrophic Cardiomyopathy (HCM)

Interventions

  • Aficamten (5 - 20 mg)Drug

    Aficamten tablets, 5-20 mg daily, administered orally. Participants may continue on Aficamten until end of treatment criteria defined in the protocol is met.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events observed during dosing of aficamten in patients with HCMTime frame: Baseline to End of study, up to 5 years
  2. Incidence of serious adverse events observed during dosing of aficamten in patients with HCMTime frame: Baseline to End of study, up to 5 years
  3. Incidence of left ventricular ejection fraction (LVEF) < 50% observed during dosing of aficamten in patients with HCMTime frame: Baseline to End of study, up to 5 years

Locations

141 sites in 19 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Alaska Heart and Vascular Institute

    Anchorage, Alaska

  • Mayo Clinic Building - Phoenix

    Phoenix, Arizona

  • UC San Diego Health - Sulpizio Cardiovascular Center

    La Jolla, California

  • Cedar-Sinai Medical Center

    Los Angeles, California

  • Cedars-Sinai Medical Center (Smidt Heart Institute)

    Los Angeles, California

  • UCLA Health System - UCLA Cardiovascular Center

    Los Angeles, California

  • UCSF Medical Center

    San Francisco, California

  • Yale New Haven Hospital

    New Haven, Connecticut

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • Holy Cross Hospital / Cardiology Associates

    Fort Lauderdale, Florida

  • Emory Clinic

    Atlanta, Georgia

  • Piedmont Fayette Hospital

    Fayetteville, Georgia

  • The Queen's Medical Center

    Honolulu, Hawaii

  • Northwestern University

    Chicago, Illinois

  • The University of Iowa Hospitals & Clinics

    Iowa City, Iowa

  • The University of Kansas Medical Center

    Kansas City, Kansas

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts

  • Michigan Medicine - University of Michigan

    Ann Arbor, Michigan

  • University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Center)

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri

  • Morristown Medical Center

    Morristown, New Jersey

  • Northwell Health North Shore University Hospital

    Manhasset, New York

  • NYU Langone Health

    New York, New York

  • Weill Cornell Medicine

    New York, New York

  • Mount Sinai Hospital

    New York, New York

  • Columbia University Medical Center/New York Presbyterian Hospital

    New York, New York

  • Westchester Medical Center

    Valhalla, New York

  • Sanger Heart & Vascular Institute, Atrium Health

    Charlotte, North Carolina

  • Duke Cardiology at Southpoint

    Durham, North Carolina

  • The Linder Research Center at The Christ Hospital

    Cincinnati, Ohio

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Ascension St. John Clinical Research Institute

    Tulsa, Oklahoma

  • Providence St. Vincent Medical Center

    Portland, Oregon

Showing 40 of 141 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.